C07K 16/1225
From bordetella
Official title: {from Bordetella (G)}
C07K16/1225 (From bordetella) appears on 21 US grants and 23 published applications in this corpus.
Search patents in C07K- Granted patents
- 21
- Published applications
- 23
- Assignees
- 17
- Inventors
- 47
- Latest grant
- 26 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 3 | 2 |
| 2015 | 0 | 3 |
| 2016 | 4 | 3 |
| 2017 | 0 | 2 |
| 2018 | 2 | 3 |
| 2019 | 1 | 1 |
| 2020 | 2 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 4 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods and compositions for pertussis diagnosis26 Dec 2023US 11,851,479 B2Dxdiscovery, Inc.
- Bispecific pertussis antibodies21 Jan 2020US 10,538,579 B2Board of Regents, The University of Texas System
- Humanized pertussis antibodies and used thereof7 Jan 2020US 10,526,400 B2Board of Regents, The University of Texas System
- Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist11 Jun 2019US 10,314,904 B2Regeneron Pharmaceuticals, Inc.
- Canine health product containing antibodies against canine parvovirus type 29 Oct 2018US 10,092,647 B2Mars, Incorporated
- Methods and compositions for pertussis diagnosis21 Mar 2024US 2024/0092877 A1Dx Discovery Inc.
- Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist14 Mar 2024US 2024/0082380 A1Regeneron Pharmaceuticals, Inc.
- Systems and methods to link cd40 signaling to antigen binding15 Feb 2024US 2024/0052013 A1Fred Hutchinson Cancer Center
- Cross-protective antigens for vaccination8 Feb 2024US 2024/0042003 A1West Virginia University Board of Governors on behalf of West Virginia University
- Pertussis toxin binding protein2 Mar 2023US 2023/0061378 A1Suzhou Alphamab Co., Ltd.
Most cited
By later US patents
- Adenyl cyclase derivatives and their biological uses14US 5,183,745 AInstitut Pasteur · 1993
- Antibody recognizing endothelial cell ligand for leukocyte CR39US 5,792,457 AThe Rockefeller University · 1998
- Peptides which inhibit adhesion between leukocytes and endothelial cells8US 5,932,217 AThe Rockefeller University · 1999
- Polypeptide pertussis toxin vaccine6US 5,000,952 AThe Board of Trustees of the Leland Stanford Jr. University · 1991
- Pertussis antibodies and uses thereof5US 8,653,243 B2Board of Regents, The University of Texas System · 2014